Trial Profile
Visualisation of [18]F-THK5351 binding in primary progressive aphasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Aug 2017
Price :
$35
*
At a glance
- Drugs Fluorine 18 THK 5351 (Primary)
- Indications Primary progressive aphasia
- Focus Diagnostic use
- 28 Aug 2017 New trial record
- 20 Jul 2017 Results presented at the Alzheimer's Association International Conference 2017